Zivo Bioscience Inc (ZIVO)

$8.35

-0.14

(-1.65%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $8.35
    $8.50
    $8.35
    downward going graph

    0.0%

    Downside

    Day's Volatility :1.76%

    Upside

    1.76%

    downward going graph
  • $0.48
    $13.00
    $8.35
    downward going graph

    94.25%

    Downside

    52 Weeks Volatility :96.31%

    Upside

    35.77%

    downward going graph

Returns

PeriodZivo Bioscience IncIndex (Russel 2000)
3 Months
4.81%
0.0%
6 Months
-15.1%
0.0%
1 Year
-29.25%
0.0%
3 Years
-61.65%
-20.2%

Highlights

Market Capitalization
24.9M
Book Value
- $0.81
Earnings Per Share (EPS)
-3.81
PEG Ratio
0.0
Wall Street Target Price
12.0
Profit Margin
0.0%
Operating Margin TTM
-3571.78%
Return On Assets TTM
-422.29%
Return On Equity TTM
-3956.02%
Revenue TTM
63.4K
Revenue Per Share TTM
0.03
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
20.0K
Diluted Eps TTM
-3.81
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.64
EPS Estimate Next Year
-1.2
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Zivo Bioscience Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 43.71%

Current $8.35
Target $12.00

Technicals Summary

Sell

Neutral

Buy

Zivo Bioscience Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zivo Bioscience Inc
Zivo Bioscience Inc
30.62%
-15.1%
-29.25%
-61.65%
-66.23%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zivo Bioscience Inc
Zivo Bioscience Inc
NA
NA
0.0
-1.64
-39.56
-4.22
NA
-0.81
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zivo Bioscience Inc
Zivo Bioscience Inc
Buy
$24.9M
-66.23%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Zivo Bioscience Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 90.9%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 248.2%

Institutional Holdings

    Company Information

    zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

    Organization
    Zivo Bioscience Inc
    Employees
    8
    CEO
    Mr. John B. Payne
    Industry
    Consumer Non-Durables

    Discover More

    FAQs